{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:58:27Z","timestamp":1792760307896,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.anai.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T19:09:56Z","timestamp":1568056196000},"page":"503-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Suppression of aspirin-mediated eosinophil activation by prostaglandin E2"],"prefix":"10.1016","volume":"123","author":[{"given":"Kavita","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun M.","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Borish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer C.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Steinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2019.09.003_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2500\/ajra.2015.29.4123","article-title":"Factors driving the AERD phenotype","volume":"29","author":"Steinke","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.anai.2019.09.003_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2500\/aap.2019.40.4188","article-title":"Clinical updates in aspirin-exacerbated respiratory disease","volume":"40","author":"Laidlaw","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2019.09.003_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","article-title":"Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma","volume":"153","author":"Sestini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2019.09.003_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"Perez-Novo","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1301753","article-title":"Aspirin activation of eosinophils and mast cells:implications in the pathogenesis of aspirin-exacerbated respiratory disease","volume":"193","author":"Steinke","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2018-0175OC","article-title":"Leukotriene A4 hydrolase activation and leukotriene B4 production by eosinophils in severe asthma","volume":"60","author":"Pal","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.anai.2019.09.003_bib7","doi-asserted-by":"crossref","first-page":"16987","DOI":"10.1073\/pnas.1313185110","article-title":"Prostaglandin E2 deficiency causes a\u00a0phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes","volume":"110","author":"Liu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anai.2019.09.003_bib8","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1182\/blood-2005-07-2772","article-title":"Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses","volume":"107","author":"Feng","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.anai.2019.09.003_bib9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1189\/jlb.0212109","article-title":"E-prostanoid 2 receptors dampen mast cell degranulation via cAMP\/PKA-mediated\u00a0suppression of IgE-dependent signaling","volume":"92","author":"Serra-Pages","year":"2012","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.anai.2019.09.003_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000237600","article-title":"Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients","volume":"113","author":"Sampson","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib11","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.anai.2019.09.003_bib12","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/lary.21969","article-title":"Evidence for distinct histologic profile of nasal polyps with and without eosinophilia","volume":"121","author":"Payne","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anai.2019.09.003_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","article-title":"Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics","volume":"157","author":"Dahlen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2019.09.003_bib14","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4049\/jimmunol.168.3.1428","article-title":"Aspirin and salicylates inhibit the IL-4 and IL-13-induced activation of STAT6","volume":"168","author":"Perez","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib15","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-\u03baB by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.anai.2019.09.003_bib16","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.4049\/jimmunol.173.9.5721","article-title":"A\u00a0new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription","volume":"173","author":"Aceves","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0194599814555836","article-title":"Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study","volume":"152","author":"Sommer","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anai.2019.09.003_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/alr.21678","article-title":"A\u00a0novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a mutlicenter randomized control crossover trial","volume":"6","author":"Sommer","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.anai.2019.09.003_bib19","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.4049\/jimmunol.1101806","article-title":"Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation","volume":"187","author":"Luna-Gomes","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaci.2016.04.042","article-title":"Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease","volume":"138","author":"Feng","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib21","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s10529-006-9084-9","article-title":"Cyclooxygenase-independent effects of aspirin on HT-29 human colon cancer cells, revealed by oligonucleotide microarrays","volume":"28","author":"Yin","year":"2006","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.anai.2019.09.003_bib22","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/blood.V97.6.1742","article-title":"Selective inhibition of interleukin-4 gene expression in human T cells by aspirin","volume":"97","author":"Cianferoni","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.anai.2019.09.003_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jaci.2009.07.031","article-title":"Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: possible role in therapeutic benefit associated with aspirin desensitization","volume":"124","author":"Steinke","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjp.0706664","article-title":"Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation","volume":"147","author":"Kay","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.anai.2019.09.003_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1165\/rcmb.2004-0126OC","article-title":"Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity","volume":"32","author":"White","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.anai.2019.09.003_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4049\/jimmunol.173.1.559","article-title":"Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP","volume":"173","author":"Aronoff","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib27","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jaci.2012.02.007","article-title":"Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma","volume":"129","author":"Corrigan","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.09.003_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drudis.2016.08.003","article-title":"Structural features of subtype-selective EP receptor modulators","volume":"22","author":"Markovi\u010d","year":"2017","journal-title":"Drug Discov Today"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120619310580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120619310580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:23:27Z","timestamp":1761053007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120619310580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1081120619310580"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2019.09.003","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of aspirin-mediated eosinophil activation by prostaglandin E2","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}